214 related articles for article (PubMed ID: 11206596)
1. Divalproex sodium in substance abusers with mood disorder.
Albanese MJ; Clodfelter RC; Khantzian EJ
J Clin Psychiatry; 2000 Dec; 61(12):916-21. PubMed ID: 11206596
[TBL] [Abstract][Full Text] [Related]
2. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.
Kemp DE; Gao K; Ganocy SJ; Elhaj O; Bilali SR; Conroy C; Findling RL; Calabrese JR
J Clin Psychiatry; 2009 Jan; 70(1):113-21. PubMed ID: 19192457
[TBL] [Abstract][Full Text] [Related]
3. Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms.
Chang KD; Dienes K; Blasey C; Adleman N; Ketter T; Steiner H
J Clin Psychiatry; 2003 Aug; 64(8):936-42. PubMed ID: 12927009
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy.
Baetz M; Bowen RC
Can J Psychiatry; 1998 Feb; 43(1):73-7. PubMed ID: 9494751
[TBL] [Abstract][Full Text] [Related]
5. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
Scheffer RE; Kowatch RA; Carmody T; Rush AJ
Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
[TBL] [Abstract][Full Text] [Related]
6. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.
Donovan SJ; Stewart JW; Nunes EV; Quitkin FM; Parides M; Daniel W; Susser E; Klein DF
Am J Psychiatry; 2000 May; 157(5):818-20. PubMed ID: 10784478
[TBL] [Abstract][Full Text] [Related]
7. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.
Frankenburg FR; Zanarini MC
J Clin Psychiatry; 2002 May; 63(5):442-6. PubMed ID: 12019669
[TBL] [Abstract][Full Text] [Related]
8. Treatment of panic disorder and comorbid substance abuse with divalproex sodium.
Roberts JM; Malcolm R; Santos AB
Am J Psychiatry; 1994 Oct; 151(10):1521. PubMed ID: 8092347
[No Abstract] [Full Text] [Related]
9. Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania.
State RC; Frye MA; Altshuler LL; Strober M; DeAntonio M; Hwang S; Mintz J
J Clin Psychiatry; 2004 Aug; 65(8):1057-63. PubMed ID: 15323589
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
11. The relationship between substance abuse and bipolar disorder.
Brady KT; Sonne SC
J Clin Psychiatry; 1995; 56 Suppl 3():19-24. PubMed ID: 7883738
[TBL] [Abstract][Full Text] [Related]
12. A history of substance abuse complicates remission from acute mania in bipolar disorder.
Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
J Clin Psychiatry; 1999 Nov; 60(11):733-40. PubMed ID: 10584760
[TBL] [Abstract][Full Text] [Related]
13. Divalproex sodium in the treatment of refractory affective disorders.
Schaff MR; Fawcett J; Zajecka JM
J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
15. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study.
Brady KT; Sonne SC; Anton R; Ballenger JC
J Clin Psychiatry; 1995 Mar; 56(3):118-21. PubMed ID: 7883730
[TBL] [Abstract][Full Text] [Related]
16. Divalproex sodium to treat concomitant substance abuse and mood disorders.
Hertzman M
J Subst Abuse Treat; 2000 Jun; 18(4):371-2. PubMed ID: 10812311
[TBL] [Abstract][Full Text] [Related]
17. Current status of co-occurring mood and substance use disorders: a new therapeutic target.
Pettinati HM; O'Brien CP; Dundon WD
Am J Psychiatry; 2013 Jan; 170(1):23-30. PubMed ID: 23223834
[TBL] [Abstract][Full Text] [Related]
18. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.
Hollander E; Allen A; Lopez RP; Bienstock CA; Grossman R; Siever LJ; Merkatz L; Stein DJ
J Clin Psychiatry; 2001 Mar; 62(3):199-203. PubMed ID: 11305707
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine in patients with bipolar disorder and cocaine dependence.
Brown ES; Nejtek VA; Perantie DC; Orsulak PJ; Bobadilla L
J Clin Psychiatry; 2003 Feb; 64(2):197-201. PubMed ID: 12633129
[TBL] [Abstract][Full Text] [Related]
20. Medical and substance use comorbidity in bipolar disorder.
Kemp DE; Gao K; Ganocy SJ; Caldes E; Feldman K; Chan PK; Conroy C; Bilali S; Findling RL; Calabrese JR
J Affect Disord; 2009 Jul; 116(1-2):64-9. PubMed ID: 19100627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
